Human Immunodeficiency Virus Type 1

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2013-04-09
Clinical Trial Update: A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study [Phase 2]
Phase 2 study of TMC125 (rilpivirine) in HIV-1 infected patients; results were posted in 2013.